first
study
give
ketamine
severely
depressed
patients
found
dramatic
positive
effects
long
standing
sufferers
responded
treatments
government
announced
february
ketamine
would
upgraded
class
banned
substance
face
evidence
caused
physical
psychological
harm
recreational
users
researchers
oxford
health
nhs
foundation
trust
university
oxford
observed
patients
study
suffered
depression
years
experienced
significant
improvement
mood
four
seven
days
final
dose
drug
four
subjects
completely
free
depression
point
rupert
mcshane
consultant
psychiatrist
oxford
health
researcher
oxford
university
department
psychiatry
warned
self
medication
emphasising
patients
trial
carefully
monitored
said
really
dramatic
people
sort
thing
really
makes
worth
psychiatry
seen
remarkable
changes
people
severe
depression
many
years
treatment
touched
moving
witness
patients
often
comment
flow
thinking
seems
suddenly
freer
one
people
suffer
form
depression
life
mcshane
estimates
people
suffer
moderate
severe
depression
responded
treatment
oxford
study
published
journal
psychopharmacology
thursday
involved
patients
treatment
resistant
depression
given
either
three
six
intravenous
infusions
ketamine
lasting
minutes
warneford
hospital
ect
clinic
oxford
four
seven
days
final
infusion
eight
responded
treatment
measured
depression
score
falling
four
remission
among
responded
ketamine
duration
benefit
varied
widely
days
eight
months
median
months
ketamine
seen
researchers
substitute
electroconvulsive
therapy
ect
sometimes
used
people
treatment
resistant
depression
carries
risk
memory
loss
one
reasons
drug
thought
work
direct
impact
subgenual
anterior
cingulate
part
brain
overactivity
seen
people
depression
works
rapidly
compared
antidepressants
take
days
take
effect
one
reasons
ketamine
upgraded
class
associated
major
bladder
problems
experienced
patients
trial
given
half
amount
typical
recreational
dose
although
heavy
users
drug
popular
among
clubbers
take
several
grammes
day
patients
experienced
distorted
perceptions
felt
disconnected
body
infusion
feel
euphoric
suffer
loss
memory
side
effects
experienced
included
anxiety
infusion
vomiting
one
patient
fainted
episodes
suicidal
behaviour
occurred
study
unusual
given
patients
severely
depressed
researchers
said
suicidal
ideas
diminished
overall
main
thing
work
maintenance
strategy
try
prolong
responses
ketamine
said
controversial
area
doubt
got
potential
anticipate
reclassification
drug
causing
problems
noting
already
widely
used
relief
chronic
pain
